Toll in the vessel wall - For better or worse?

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 7, 2011, Pages 2637-2638

  Hansson, Göran K ^a   Lundberg, Anna M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 3; LIVER X RECEPTOR; POLYINOSINIC POLYCYTIDYLIC ACID; RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ARTERY INJURY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CHRONIC INFLAMMATION; CPG ISLAND; DNA METHYLATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STROKE;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 79952589220     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019722108     Document Type: Note

References (17)

1. Casanova JL, Abel L, Quintana-Murci L (2010) Human TLRs and IL-1Rs in host defense: Natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol, in press.
2. Cole JE, et al. (2011) Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc Natl Acad Sci USA 108:2372-2377.
3. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695.
4. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ (2002) Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105:1158-1161. (Pubitemid 34225814)
5. Curtiss LK, Tobias PS (2009) Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 50 (Suppl): S340-S345.
6. Lundberg AM, Hansson GK (2010) Innate immune signals in atherosclerosis. Clin Immunol 134:5-24.
7. Michelsen KS, et al. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101:10679-10684. (Pubitemid 38955802)
8. Mullick AE, Tobias PS, Curtiss LK (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115:3149-3156. (Pubitemid 41567579)
9. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738. (Pubitemid 33009951)
10. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D (2004) mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279:12542-12550. (Pubitemid 38445825)
11. Cavassani KA, et al. (2008) TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205:2609-2621.
12. Castrillo A, et al. (2003) Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 12:805-816. (Pubitemid 37352775)
13. Sun Y, et al. (2009) Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ Res 104:455-465.
14. Yang X, et al. (2006) Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 291:H2334-H2343.
15. Ahmad U, et al. (2010) IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5. J Immunol 185:1283-1294.
16. Hansson GK, Robertson AKL, Söderberg-Nauclér C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297-329.
17. Lundberg AM, et al. (2007) Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: A phenomenon absent from murine cell systems. Blood 110:3245-3252. (Pubitemid 350106317)